Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.80)
# 3,323
Out of 5,149 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $30.25 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $30.65 | +124.31% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $1.66 | +321.69% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.75 | +1,901.87% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $360 | $1.14 | +31,478.95% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $94.94 | -63.13% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $22.45 | +122.72% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $4.27 | +35,497.19% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $10.11 | +938.58% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $42.73 | -32.13% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $6.01 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $30.25
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $30.65
Upside: +124.31%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.66
Upside: +321.69%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.75
Upside: +1,901.87%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $360
Current: $1.14
Upside: +31,478.95%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $94.94
Upside: -63.13%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $22.45
Upside: +122.72%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $4.27
Upside: +35,497.19%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $10.11
Upside: +938.58%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $42.73
Upside: -32.13%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $6.01
Upside: -